Massachusetts Financial Services CO Bioventus Inc. Transaction History

Massachusetts Financial Services CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$2.89 - $5.34 $5,040 - $9,312	-1,744 Reduced 3.06%	55,238 $291,000
Q3 2023 Nov 08, 2023	SELL	$2.8 - $4.94 $6,115 - $10,788	-2,184 Reduced 3.69%	56,982 $188,000
Q2 2023 Aug 09, 2023	SELL	$0.93 - $3.64 $80,613 - $315,518	-86,681 Reduced 59.43%	59,166 $170,000
Q1 2023 May 10, 2023	SELL	$1.07 - $2.95 $4,412 - $12,165	-4,124 Reduced 2.75%	145,847 $156,000
Q4 2022 Feb 13, 2023	BUY	$1.81 - $8.14 $5,746 - $25,844	3,175 Added 2.16%	149,971 $391,000
Q3 2022 Nov 09, 2022	SELL	$6.54 - $9.08 $8,743 - $12,139	-1,337 Reduced 0.9%	146,796 $1.03 Million
Q2 2022 Aug 09, 2022	BUY	$6.82 - $13.82 $220,702 - $447,229	32,361 Added 27.95%	148,133 $1.01 Million
Q1 2022 May 11, 2022	BUY	$11.65 - $15.28 $1.15 Million - $1.5 Million	98,302 Added 562.69%	115,772 $1.63 Million
Q4 2021 Feb 10, 2022	BUY	$12.37 - $16.77 $216,103 - $292,971	17,470 New	17,470 $253,000

142

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $622M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.